KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Cash from Investing Activities (2020 - 2025)

Clover Health Investments' Cash from Investing Activities history spans 6 years, with the latest figure at -$35.0 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 2331.9% year-over-year to -$35.0 million; the TTM value through Dec 2025 reached $4.1 million, up 621.42%, while the annual FY2025 figure was $4.1 million, 621.42% up from the prior year.
  • Cash from Investing Activities reached -$35.0 million in Q4 2025 per CLOV's latest filing, down from -$5.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $170.9 million in Q2 2021 to a low of -$257.5 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$9.8 million, with a median of $6.9 million recorded in 2024.
  • The largest YoY upside for Cash from Investing Activities was 1306.42% in 2021 against a maximum downside of 16256.33% in 2021.
  • A 5-year view of Cash from Investing Activities shows it stood at -$106.5 million in 2021, then soared by 111.88% to $12.7 million in 2022, then surged by 561.05% to $83.7 million in 2023, then plummeted by 101.72% to -$1.4 million in 2024, then crashed by 2331.9% to -$35.0 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Cash from Investing Activities are -$35.0 million (Q4 2025), -$5.4 million (Q3 2025), and $35.6 million (Q2 2025).